home.aspx
 
EVENTS

4th World Biotechnology & Biofuels Congress
4TH WORLD BIOTECHNOLOGY & BIOFUELS CONGRESS
December 06-07, 2019
World Biotechnology 2019 has been finalized to take place during December 06-07, 2019 in Sao Paulo, Brazil and will initiate its journey towards its aim of unifying people from different corners around the globe with the theme “Novel Insights and Innovations in Biotechnology for Leading a Bett...

Food Microbiology and Food Market Meeting
FOOD MICROBIOLOGY AND FOOD MARKET MEETING
December 06-07, 2019
In this International meeting participants from all over the globe will gather under one roof. This pinnacle will bring together the senior level experts with a perfect combination of  multidisciplinary collaboration between innovators, scientists, academicians, Microbiologists from all over th...

BioTech Annecto

BioTech Annecto is a social networking organization, whose aim is to bring together entrepreneurs, investors, scientists, attorneys, journalists and other professionals in the biotechnology sector: pharmaceutical, healthcare and biomedical, cosmetics, and environment. Launched February 2009 in Montreal (Quebec, Canada), BioTech Annecto (previously known as BioTech Montreal) is inviting people, one Tuesday every month, from the Montreal biotechnology community to meet at trendy locations around town. Members come from the business world, from public agencies as well as academic institutions. This allows regular communication and exchanges between industry, the public sector and academia.

RELATED NEWS


The ongoing report on Pharmaceutical & Biotechnology Environmental Monitoring Market-Global Industry Analysis and Forecast to 2022 refreshed by Alexa Reports offers a wide viewpoint of current patterns controlling over the worldwide market. The report highlights information review by key players’ profiles, and their advancements in the field. Our exploration examiners have utilized approved information and essential research sources to give the market inquired report. The report public...

READ MORE

E. coli are hardy bacteria, able to live in diverse conditions from the surface of a lettuce leaf to an acidic stomach. To survive and thrive in so many environments, the bacteria must use a network of transcriptional regulators to change their gene expression levels in response to their surroundings. Even in E. coli, one of the best characterized bacteria, it is still a significant challenge for scientists to understand how they coordinate the expression of their thousands of genes. learning al...

READ MORE

Inflammation is a hallmark of many health conditions, but quantifying how the underlying biology of inflammation contributes to specific diseases has been difficult. For the first time, UNC School of Medicine researchers and colleagues now report the development of a new technology to identify white blood cells called neutrophils that are primed to eject inflammatory DNA into the circulation via a process called NETosis. The findings, published in Scientific Reports, mark the first time scientis...

READ MORE

Aberdeen announced Aberdeen Intent for Salesforce the first Salesforce-native solution that identifies and pushes intent-qualified opportunities directly into your Salesforce instance so your sales team never misses another deal. Aberdeen Intent for Salesforce uses machine learning to track the online research of millions of companies across the internet to generate the most accurate intent score available with client measured accuracy as high as 91%.Aberdeen Intent for Salesforce is based on th...

READ MORE

Aberdeen, a research firm and intent-based sales and marketing solutions provider, supported by Kapost, recently released new research showing best-in-class B2B firms significantly benefit by executing on consistent, intentional content strategies supporting end-to-end customer experience (CX). Best-in-Class firms see 48% greater customer lifetime value (LTV) and nearly 300% greater year-over-year improvement in customer effort scores.The considered purchase process today is long and involves a ...

READ MORE

Aberdeen announced Aberdeen Behavioral Technographics – the industry’s first install (technographic) data that actively measures technology in use. Legacy technographic data only provides a single yes/no estimate as to whether a company uses a specific technology. Aberdeen Behavioral Technographics is the first to measure technology usage down to company location, number of users and pains and priorities of the usage.In numerous tests, Aberdeen Behavioral Technographics has proven to...

READ MORE

Crispr Therapeutics AG (CRSP) is near the top in its industry group according to InvestorsObserver. CRSP gets an overall rating of 72. That means it scores higher than 72 percent of stocks. Crispr Therapeutics AG gets a 91 rank in the Biotechnology industry. Biotechnology is number 76 out of 148 industries. Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. I...

READ MORE

Amgen received two approvals from regulators over the Thanksgiving weekend, allowing its deal to acquire a minority stake in a Chinese biotechnology firm to move forward and granting orphan drug status to anemia treatment Nplate. The Thousand Oaks-based pharma giant announced the deal to acquire a 20 percent stake in oncology research firm BeiGene for $2.7 billion in late October and got the nod from the Federal Trade Commission Nov. 29. The approval came just two days after the U.S. Food and Dr...

READ MORE

Cyrus Biotechnology, Inc., and the Broad Institute of MIT and Harvard have embarked on a scientific collaboration to optimize CRISPR for use in developing novel human therapeutics. CRISPR allows for the highly specific and rapid modification of DNA in a genome, which can dramatically accelerate the drug discovery process. Feng Zhang will be the principal investigator for the Broad for the collaboration. He is also an investigator of the Howard Hughes Medical Institute (HHMI). Together, researche...

READ MORE

Neurocrine Biosciences has agreed to exclusively license and co-develop Xenon Pharmaceuticals’ Phase I epilepsy candidate XEN901 as a treatment for children—as well as develop three preclinical compounds, the companies said today—through a collaboration that could generate up to $1.7 billion for Xenon. XEN901 is designed as a highly selective Nav1.6 sodium channel inhibitor being developed to treat children with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE) and o...

READ MORE

EVENTS

Food Microbiology and Food Market Meeting
FOOD MICROBIOLOGY AND FOOD MARKET MEETING
December 06-07, 2019
In this International meeting participants from all over the globe will gather under one roof. This pinnacle will bring together the senior level experts with a perfect combination of  multidisciplinary collaboration between innovators, scientists, academicians, Microbiologists from all over th...

4th World Biotechnology & Biofuels Congress
4TH WORLD BIOTECHNOLOGY & BIOFUELS CONGRESS
December 06-07, 2019
World Biotechnology 2019 has been finalized to take place during December 06-07, 2019 in Sao Paulo, Brazil and will initiate its journey towards its aim of unifying people from different corners around the globe with the theme “Novel Insights and Innovations in Biotechnology for Leading a Bett...